Colorectal cancer is the second-leading cause of cancer death among Native Americans, prompting calls for increased screenings to improve detection and treatment of colorectal disease. The University of Arizona Cancer Center is working to address this problem. The program was recently awarded $3 million by the National Cancer Institute’s Cancer Moonshot Initiative, which aims to accelerate cancer research and prevention.

A new study from scientists at the University of Arizona Health Sciences center shows that the novel coronavirus has a second receptor that is linked to pain signaling.

In a small preliminary study, researchers affiliated with the University of Arizona Health Sciences Comprehensive Pain and Addiction Center exposed 29 people—all of whom experience episodic or chronic migraine and failed multiple traditional therapies, such as oral medications and Botox injections— to white and green light.

Q&A with Environmental microbiologists and public health researchers at the University of Arizona: Kelly Reynolds, professor and chair of the Community, Environment and Policy Department at the Mel and Enid Zuckerman College of Public Health and Charles Gerba, an environmental microbiologist from the College of Agriculture and Life Sciences.

Antibodies normally fight viruses, but in the case of flaviviruses, they can make infections worse. UArizona Health Sciences immunologists figured out why.

Antibodies normally fight viruses, but in the case of flaviviruses, they can make infections worse. Researchers took a closer look at antibody production to figure out why.

Payson now has a state-of-the-art, high-tech telemedicine clinic, with the opening of the University of Arizona College of Medicine – Phoenix Rural Health Clinic. The clinic will train medical students and also offer treatment for everyone regardless of medical insurance status, taking advantage of the latest technology to run tests, talk to specialists and manage the care of complex medical issues.

An unexpected finding gives researchers in the UArizona Health Sciences Comprehensive Pain and Addiction Center a novel target for non-opioid pain therapeutics.

Research shows SARS-CoV-2 promotes pain relief through the receptor neuropilin-1, which gives scientists a new target for non-opioid pain therapeutics and offers one possible explanation for the unrelenting spread of COVID-19.

White House Coronavirus Task Force Coordinator Dr. Deborah Birx tours labs to learn about Health Sciences’ antibody and antigen testing.